Cargando…

Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study

OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Retrospective cohort study. SETTING: University-based hospital....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Shan, Liu, Minghui, Li, Lingxiu, Li, Huanhuan, Qu, Danni, Ren, Haiying, Su, Hui, Zhang, Yang, Li, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314175/
https://www.ncbi.nlm.nih.gov/pubmed/34326810
http://dx.doi.org/10.3389/fendo.2021.618580
_version_ 1783729493917040640
author Liu, Shan
Liu, Minghui
Li, Lingxiu
Li, Huanhuan
Qu, Danni
Ren, Haiying
Su, Hui
Zhang, Yang
Li, Yuan
author_facet Liu, Shan
Liu, Minghui
Li, Lingxiu
Li, Huanhuan
Qu, Danni
Ren, Haiying
Su, Hui
Zhang, Yang
Li, Yuan
author_sort Liu, Shan
collection PubMed
description OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Retrospective cohort study. SETTING: University-based hospital. PATIENTS: 110 patients exhibited ultra-low LH levels during ovarian stimulation using GnRH agonist long protocol. INTERVENTION(S): As all the embryos in the first cycle were exhausted without being pregnant, these patients proposed to undergo a second cycle of ovarian stimulation. 74 of them were treated with a modified GnRH antagonist protocol based on LH levels. Other 36 patients were still stimulated following GnRH agonist long protocol. MAIN OUTCOME MEASURE: The primary outcome was live birth rate (LBR). The second outcomes were biochemical pregnancy rate, clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and cancellation rate. RESULTS: Reproductive outcomes were much better in the modified GnRH antagonist protocol. The OPR and LBR were much higher in the GnRH antagonist protocol group than in the GnRH agonist long protocol group [odds ratio (OR) 3.82, 95% confidence interval (CI) 1.47, 10.61, P=0.018; OR 4.33, 95% CI 1.38, 13.60, P=0.008; respectively]. Meanwhile, the cancellation rate was much lower in the GnRH antagonist protocol group (OR 0.13, 95% CI 0.02, 0.72; P=0.014). Mean LH level during stimulation did not have a predictive value on live birth. However, it was independently associated with the occurrence of ongoing pregnancy (OR 2.70, 95% CI 1.25, 5.85; P=0.01). The results of sensitivity analyses were consistent with the data mentioned above. The patients got completely different and excellent clinical outcomes in their second cycles stimulated with the modified GnRH antagonist protocol. CONCLUSION: Patients with deep ovarian suppression following GnRH agonist long protocol may benefit from a modified GnRH antagonist protocol based on LH levels.
format Online
Article
Text
id pubmed-8314175
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83141752021-07-28 Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study Liu, Shan Liu, Minghui Li, Lingxiu Li, Huanhuan Qu, Danni Ren, Haiying Su, Hui Zhang, Yang Li, Yuan Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: To verify if patients with deep ovarian suppression following gonadotropin releasing hormone (GnRH) agonist long protocol may benefit from a modified GnRH antagonist protocol based on luteinizing hormone (LH) levels. DESIGN: Retrospective cohort study. SETTING: University-based hospital. PATIENTS: 110 patients exhibited ultra-low LH levels during ovarian stimulation using GnRH agonist long protocol. INTERVENTION(S): As all the embryos in the first cycle were exhausted without being pregnant, these patients proposed to undergo a second cycle of ovarian stimulation. 74 of them were treated with a modified GnRH antagonist protocol based on LH levels. Other 36 patients were still stimulated following GnRH agonist long protocol. MAIN OUTCOME MEASURE: The primary outcome was live birth rate (LBR). The second outcomes were biochemical pregnancy rate, clinical pregnancy rate (CPR), ongoing pregnancy rate (OPR) and cancellation rate. RESULTS: Reproductive outcomes were much better in the modified GnRH antagonist protocol. The OPR and LBR were much higher in the GnRH antagonist protocol group than in the GnRH agonist long protocol group [odds ratio (OR) 3.82, 95% confidence interval (CI) 1.47, 10.61, P=0.018; OR 4.33, 95% CI 1.38, 13.60, P=0.008; respectively]. Meanwhile, the cancellation rate was much lower in the GnRH antagonist protocol group (OR 0.13, 95% CI 0.02, 0.72; P=0.014). Mean LH level during stimulation did not have a predictive value on live birth. However, it was independently associated with the occurrence of ongoing pregnancy (OR 2.70, 95% CI 1.25, 5.85; P=0.01). The results of sensitivity analyses were consistent with the data mentioned above. The patients got completely different and excellent clinical outcomes in their second cycles stimulated with the modified GnRH antagonist protocol. CONCLUSION: Patients with deep ovarian suppression following GnRH agonist long protocol may benefit from a modified GnRH antagonist protocol based on LH levels. Frontiers Media S.A. 2021-07-13 /pmc/articles/PMC8314175/ /pubmed/34326810 http://dx.doi.org/10.3389/fendo.2021.618580 Text en Copyright © 2021 Liu, Liu, Li, Li, Qu, Ren, Su, Zhang and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Liu, Shan
Liu, Minghui
Li, Lingxiu
Li, Huanhuan
Qu, Danni
Ren, Haiying
Su, Hui
Zhang, Yang
Li, Yuan
Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
title Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
title_full Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
title_fullStr Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
title_full_unstemmed Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
title_short Patients With Deep Ovarian Suppression Following GnRH Agonist Long Protocol May Benefit From a Modified GnRH Antagonist Protocol: A Retrospective Cohort Study
title_sort patients with deep ovarian suppression following gnrh agonist long protocol may benefit from a modified gnrh antagonist protocol: a retrospective cohort study
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8314175/
https://www.ncbi.nlm.nih.gov/pubmed/34326810
http://dx.doi.org/10.3389/fendo.2021.618580
work_keys_str_mv AT liushan patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT liuminghui patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT lilingxiu patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT lihuanhuan patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT qudanni patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT renhaiying patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT suhui patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT zhangyang patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy
AT liyuan patientswithdeepovariansuppressionfollowinggnrhagonistlongprotocolmaybenefitfromamodifiedgnrhantagonistprotocolaretrospectivecohortstudy